Urokinase Receptor Mediates Doxorubicin-Induced Vascular Smooth Muscle Cell Senescence via Proteasomal Degradation of TRF2
doi: 10.1159/000343000
pmid: 23172421
Urokinase Receptor Mediates Doxorubicin-Induced Vascular Smooth Muscle Cell Senescence via Proteasomal Degradation of TRF2
The anthracycline doxorubicin is a widely used effective anti-cancer drug. However, its application and dosage are severely limited due to its cardiotoxicity. The exact mechanisms of doxorubicin-induced cardiotoxic side effects remain poorly understood. Even less is known about the impact of doxorubicin treatment on vascular damage. We found that low doses of doxorubicin induced a senescent response in human primary vascular smooth muscle cells (VSMC). We observed that expression of urokinase receptor (uPAR) was upregulated in response to doxorubicin. Furthermore, the level of uPAR expression played a decisive role in developing doxorubicin-induced senescence. uPAR silencing in human VSMC by means of RNA interference as well as uPAR knockout in mouse VSMC resulted in abrogation of doxorubicin-induced cellular senescence. On the contrary, uPAR overexpression promoted VSMC senescence. We further found that proteasomal degradation of telomeric repeat binding factor 2 (TRF2) mediates doxorubicin-induced VSMC senescence. Our results demonstrate that uPAR controls the ubiquitin-proteasome system in VSMC and regulates doxorubicin-induced TRF2 ubiquitination and proteasomal degradation via this mechanism. Therefore, VSMC senescence induced by low doses of doxorubicin may contribute to vascular damage upon doxorubicin treatment. uPAR-mediated TRF2 ubiquitination and proteasomal degradation are further identified as a molecular mechanism underlying this process.
- Hannover Medical School Germany
Proteasome Endopeptidase Complex, Recombinant Fusion Proteins, Myocytes, Smooth Muscle, Primary Cell Culture, Telomere, Transfection, Muscle, Smooth, Vascular, Receptors, Urokinase Plasminogen Activator, Mice, Inbred C57BL, Mice, Gene Expression Regulation, Doxorubicin, Animals, Humans, RNA Interference, Telomeric Repeat Binding Protein 2, RNA, Small Interfering, Protein Processing, Post-Translational, Cells, Cultured, Cellular Senescence
Proteasome Endopeptidase Complex, Recombinant Fusion Proteins, Myocytes, Smooth Muscle, Primary Cell Culture, Telomere, Transfection, Muscle, Smooth, Vascular, Receptors, Urokinase Plasminogen Activator, Mice, Inbred C57BL, Mice, Gene Expression Regulation, Doxorubicin, Animals, Humans, RNA Interference, Telomeric Repeat Binding Protein 2, RNA, Small Interfering, Protein Processing, Post-Translational, Cells, Cultured, Cellular Senescence
14 Research products, page 1 of 2
- 2017IsRelatedTo
- 2018IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
chevron_left - 1
- 2
chevron_right
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).34 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
